SI investment contract between JW pharmaceutical and S&E bio

JW Pharmaceutical (중외제약) announced on the 17th of Nov 2022 that it has signed a strategic investment (SI) contract with S&E bio to strengthen its open innovation strategy (open innovation). The detailed news can be found at the link below.


https://www.medifonews.com/news/article.html?no=172508 ​

목록